Chronic Kidney Disease Clinical Trial
Official title:
Increasing Kidney Transplant Among Blacks on the Transplant Waiting List
Verified date | December 2019 |
Source | St. Barnabas Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
For most patients with kidney failure, living donor kidney transplant (LDKT) is their best treatment option. Unfortunately, Blacks (vs. non-Blacks) are more likely to have kidney failure but less likely to receive LDKTs. In this study, the investigators will test an intervention designed to address this disparity, by performing a parallel group, two-arm randomized clinical trial among 500 Black kidney transplant candidates. The main objective of this study is to test an educational and behavioral intervention that is designed to increase receipt of LDKT among transplant candidates (persons active on the deceased donor kidney transplant waiting list) who are Black. Our overall hypothesis is that a multi-component intervention administered to Black transplant candidates will increase both readiness to pursue LDKT and actual receipt of LDKTs. The investigators will randomly assign kidney transplant candidates on the kidney transplant waiting list to either: (1) a control group that will receive Usual Care, or (2) an Intervention group that will receive a group-based intervention, as well as monthly mailings and a follow-up phone call by a transplant educator.
Status | Completed |
Enrollment | 223 |
Est. completion date | August 2018 |
Est. primary completion date | February 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 21 Years and older |
Eligibility |
Inclusion Criteria: - self-reported as Black or African-American - 21 years of age or older - active on kidney transplant waiting list at Saint Barnabas Medical Center Exclusion Criteria: - limited English proficiency - unable or unwilling to provide informed consent - unable to complete in-person and telephone questionnaires (including hearing impairment or low vision) - lack a working telephone - live 150 miles or greater from transplant center - enrolled in prior randomized intervention trial, NCT01261910, at our center - currently already scheduled to receive a live donor kidney transplant - active on the simultaneous pancreas-kidney transplant waiting list |
Country | Name | City | State |
---|---|---|---|
United States | Saint Barnabas Medical Center | Livingston | New Jersey |
Lead Sponsor | Collaborator |
---|---|
St. Barnabas Medical Center | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Rutgers University, University of California, Los Angeles |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change in knowledge of LDKT at 1 week post-intervention | We will assess knowledge of transplant and LDKT using a questionnaire containing multiple-choice and true-false questions. Each patient in the Usual Care arm will be matched to a patient in the Intervention arm. One week after attending the Intervention, each patient in the Intervention arm and the Intervention patient's matched Usual Care patient will have their knowledge of LDKT assessed. We will compare this score to the score obtained at baseline. | Baseline, 1 week post-intervention | |
Other | Change in readiness to pursue LDKT at 1 week post-intervention | We will measure an increase in study participants' readiness to pursue LDKT, assessed by their Stage of Change regarding pursuing living donation, based upon James Prochaska's Transtheoretical Model. The Stages of Change regarding pursuit of live donation include: not considering (Pre-contemplation), considering (Contemplation), preparing to pursue (Preparation), or taking action to pursue (Action) living donation within the next 6 months. Each patient in the Usual Care arm will be matched to a patient in the Intervention arm. One week after attending the Intervention, each patient in the Intervention arm and the Intervention patient's matched Usual Care patient will have their Stage of Change assessed. | Baseline, 1 week post-intervention | |
Primary | Change in readiness to pursue LDKT at 9 months | Our primary outcome is the proportion of study participants with an increase in their readiness to pursue LDKT. Readiness to pursue LDKT is assessed by the patient's Stage of Change regarding pursuing live donation, based upon James Prochaska's Transtheoretical Model. The Stages of Change regarding pursuit of living donation include: not considering (Pre-contemplation), considering (Contemplation), preparing to pursue (Preparation), or taking action to pursue (Action) living donation within the next 6 months. Stage of Change will be assessed at baseline and at 9 months post-baseline. | Baseline, 9 months | |
Secondary | Receipt of a LDKT | Among trial participants, we will determine whether or not they received a LDKT in the United States during the 18 months after they were enrolled in the trial and randomized. This determination will be made by examining each study participant's medical records. | 18 months | |
Secondary | Number of donor volunteers recruited and evaluated | We will examine each study participant's medical records to determine how many living donor volunteers contacted the transplant center to donate and how many donor volunteers were evaluated by the transplant center, during the 18 month follow-up period. | 18 months | |
Secondary | Status on kidney transplant waiting list | After 18 months of follow-up, for study participants who remain on the waiting list, we will determine whether they are: ?active (Status 1), or ?inactive (Status 7) on the waiting list. Other patients will have been removed from the Saint Barnabas Medical Center (SBMC) waiting list because they: ?died; ?became too sick to transplant; ?refused transplant; ?transferred to another center; ?improved and no longer required transplant; ?received a DDKT; ?received a LDKT; or ?other. We will determine these reasons, along with the date they occurred, by examining the medical records for each patient. | 18 months | |
Secondary | Change in knowledge of LDKT at 9 months | We will assess knowledge of transplant and LDKT at baseline and 9 months, using a questionnaire containing multiple-choice and true-false questions. | Baseline, 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Terminated |
NCT04043026 -
The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
|
||
Completed |
NCT05318014 -
Low-protein Formula Supplements in Chronic Kidney Disease
|
N/A | |
Active, not recruiting |
NCT06071065 -
Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients
|
N/A | |
Completed |
NCT02878317 -
Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
|
||
Not yet recruiting |
NCT06039254 -
Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function
|
Phase 1 | |
Recruiting |
NCT03160326 -
The QUALITY Vets Project: Muscle Quality and Kidney Disease
|
||
Completed |
NCT02836574 -
A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease
|
Phase 2 | |
Completed |
NCT02896309 -
The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity
|
N/A | |
Withdrawn |
NCT02885545 -
The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial
|
Phase 4 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02875886 -
DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT02756520 -
Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
|
||
Active, not recruiting |
NCT02483039 -
Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization
|
N/A | |
Completed |
NCT02992548 -
Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
|
Phase 4 | |
Completed |
NCT02369549 -
Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease
|
Phase 3 | |
Terminated |
NCT02543177 -
Optimised Procedure in Patients With NSTEMI and CKD
|
N/A | |
Recruiting |
NCT02205944 -
Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes
|
N/A | |
Active, not recruiting |
NCT02231138 -
Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease
|
Phase 4 |